Retinoblastoma – The Rare Eye Cancer

Retinoblastoma – The Rare Eye Cancer

Julie Scott, DNP
Julie Scott, DNP
Retinoblastoma | cancerGO

What is Retinoblastoma?

Retinoblastoma is a rare type of eye cancer that develops in the retina. The retina is the part of the eye that converts light into signals the brain uses to see. It is most commonly diagnosed in children under the age of 5, but can also occur in older people.

Risk factors

Risk factors for retinoblastoma include:

  • Having a family history
  • Inherited genetic mutations
  • Exposure to chemicals during pregnancy
  • Radiation exposure to their father

Symptoms

Symptoms of retinoblastoma can include:

  • A white pupil in photographs
  • Eye redness or pain
  • A crossed eye or lazy eye
  • Vision loss
  • Bulging of the eye
  • Bleeding in the eye

Diagnosis

Any of the above symptoms noted in children should be reported to their healthcare provider quickly. This can lead to prompt evaluation with specialized eye exams and vision tests.

Other imaging studies may be used and can include ultrasound and MRI.

For most cancers, performing a biopsy to get a tissue to test for the presence of cancer cells is done. However, this can be a very risky procedure for retinoblastoma. Because of this, it is often diagnosed by eye exams and other imaging tests.

Treatment

Treatment for retinoblastoma depends on the stage and location of cancer, the patient’s age, and overall health. Treatment options include eye-saving treatments such as:

  • Laser therapy
  • Cryotherapy (killing cancer cells by freezing them)
  • Radiation therapy
  • Chemotherapy

Other, more invasive treatment options can include surgical removal of the affected eye (enucleation) or removal of the entire eye and surrounding tissue (exenteration).

Retinoblastoma is a rare eye cancer that can affect children of all ages. Early diagnosis and treatment are essential for the best possible outcome. If you or your child have any symptoms of retinoblastoma, please see an ophthalmologist immediately.

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
GIST(Gastrointestinal stromal tumor)- What You Need to Know
December 22, 2022

What is GIST? Gastrointestinal stromal tumor, also known as GIST, is a type of cancer that develops within the gastrointestinal (GI) tract. Most GIST cancers start in the stomach wall, but they can also start in the intestines, though this isn’t as common. Exactly why GISTs start to grow is…

Julie Scott, DNP

author

Articles
The Benefit of Routine Bladder Cancer Screenings
November 21, 2022

What is Bladder Cancer? Bladder cancer is a disease in which abnormal cells begin to grow in the cells that line the bladder. Screening tests are done to look for cancer when there are no signs or symptoms. Currently, there is no screening test available for bladder cancer. However, the…

Julie Scott, DNP

author

Articles
Non-Small Cell Cancer (NSCLC)
November 7, 2022

Approximately  85% of lung cancer cases are considered NSCLC, which arises from the lung's epithelial cells, a type of cell that lines the organ surface. Several types of non-small cell lung (NSCL) include adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Non-small-cell lung cancer is when the cells in your…

Zain Syed

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice